Gerresheimer

Gerresheimer, founded in 1864, is a global leader in the manufacturing of pharmaceutical, biotechnology, and healthcare packaging solutions. The company specializes in advanced drug delivery systems and primary packaging, utilizing sophisticated material science and engineering to ensure medication safety and integrity. By providing high-quality glass and plastic containers, including vials, syringes, and insulin pens, Gerresheimer supports the entire product lifecycle for global pharmaceutical manufacturers.

Operating with 10,000+ employees across 26 global locations, the firm maintains a robust manufacturing footprint to serve diverse international markets. Their technical expertise spans borosilicate glass tubing, COP containers, and specialized medical devices designed for complex drug delivery requirements. Meet Gerresheimer's team to understand the organizational structure and leadership driving these innovations in the packaging and container industry.

Gerresheimer demonstrates significant market presence, reflected in its annual revenue of $2.7B. The company is publicly traded under the ticker FRA: GXI and continues to invest in sustainable manufacturing processes and regulatory-compliant packaging services. Explore financial highlights to review detailed performance metrics and funding history, including recent debt financing initiatives. The firm remains a critical partner for the biotechnology and well-being sectors, consistently delivering high-precision solutions that meet stringent global healthcare standards.